Omega Healthcare Investors (OHI)
(Delayed Data from NYSE)
$37.29 USD
+0.23 (0.62%)
Updated Aug 7, 2024 04:00 PM ET
After-Market: $37.28 -0.01 (-0.03%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth C Momentum D VGM
Omega Healthcare Investors (OHI) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$33.93 | $39.00 | $30.00 | -8.45% |
Price Target
Based on short-term price targets offered by 14 analysts, the average price target for Omega Healthcare Investors comes to $33.93. The forecasts range from a low of $30.00 to a high of $39.00. The average price target represents a decline of 8.45% from the last closing price of $37.06.
Analyst Price Targets (14)
Broker Rating
Omega Healthcare Investors currently has an average brokerage recommendation (ABR) of 2.53 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 15 brokerage firms. The current ABR compares to an ABR of 2.40 a month ago based on 15 recommendations.
Of the 15 recommendations deriving the current ABR, three are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 20% and 6.67% of all recommendations. A month ago, Strong Buy made up 26.67%, while Buy represented 6.67%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/OHI.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 4 | 4 | 4 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 11 | 11 | 10 | 10 | 10 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.53 | 2.53 | 2.40 | 2.40 | 2.40 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/25/2024 | Mizuho SecuritiesUSA | Vikram Malhotra | Hold | Hold |
7/9/2024 | Scotiabank | Nicholas Yulico | Hold | Hold |
6/14/2024 | Wells Fargo Securities | James Feldman | Not Available | Strong Buy |
5/28/2024 | Raymond James | Jonathan Hughes | Moderate Buy | Moderate Buy |
5/23/2024 | Wedbush Securities | Richard Anderson | Hold | Hold |
5/9/2024 | Not Identified | Not Identified | Hold | Hold |
5/6/2024 | JMP Securities | Aaron Hecht | Hold | Hold |
4/1/2024 | Truist Securities | Michael Lewis | Hold | Hold |
3/22/2024 | Not Identified | Not Identified | Hold | Strong Buy |
2/19/2024 | BMO Capital Markets | Juan Sanabria | Hold | Hold |
2/8/2024 | Exane BNP Paribas | Nathan D Crossett | Strong Sell | Hold |
1/2/2024 | Robert W. Baird & Co. | Wesley Golladay | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.53 |
ABR (Last week) | 2.53 |
# of Recs in ABR | 15 |
Average Target Price | $33.93 |
LT Growth Rate | 10.10% |
Industry | REIT and Equity Trust - Other |
Industry Rank by ABR | 100 of 253 |
Current Quarter EPS Est: | 0.70 |